S100B and neoplasm: Research should also focus in the future on patient and tumor characteristics that may predict the sensitivity of S‐100B during follow‐up, with the aim of identifying patient subgroups in which S‐100B shows higher sensitivity, to maximize the effectiveness of this tool.